Senate bill · 222
S 4601
Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.
Progress
31 days from first to latest action, across 5 recorded actions.
Filed
Sep 28
Referred to committee
Sep 28
Heard in committee
Oct 5
Reported from committee
Oct 5
Passed first chamber
Oct 22
Passed second chamber
Sent to governor
Became law
Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.
Record votes
Each dot is one member, grouped by how they voted.
Reported out of Senate committee with amendments
Senate · Oct 5, 2026
Passed 7–0
7 Yea
0 Nay
1 Absent / not voting
3RDG FINAL PASSAGE
Senate · Oct 22, 2026
Passed 39–0
39 Yea
0 Nay
1 Absent / not voting
Full history
Every action recorded by New Jersey Legislature.
Received in the Assembly, Referred to Assembly Health Committee Health
Oct 29, 2026 · General Assembly
Passed by the Senate (39-0)
Oct 22, 2026 · Senate
Reported from Senate Committee with Amendments, 2nd Reading Commerce
Oct 5, 2026 · Senate
Transferred to Senate Health, Human Services and Senior Citizens Committee
Oct 5, 2026 · Senate
Introduced in the Senate, Referred to Senate Commerce Committee Commerce
Sep 28, 2026 · Senate
Authors
and 1 coauthor or sponsor
Show 1 more
- Raj Mukherji cosponsorD